Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

Spry review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

$199/mo semaglutide, $299/mo tirzepatide, three named co-founders (Gabriel Mullins, Sara Yoder, Tyler Bowman), no contracts, and a nurse practitioner reviewing intake within roughly 24 hours by Spry's own claim — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, no pharmacy named, no state list disclosed, and nothing written for postpartum or PCOS specifically. Its pricing appears only once the page's scripts run, never in the visible marketing copy.

$199/mo
Flat price · every dose
Consult Medication
See plans at Spry
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

Spry at a glance

Semaglutide
$199/mo
Tirzepatide
$299/mo
Coverage
Not disclosed
Brand-name
Compounded only

How we scored Spry

Every factor comes from Spry's own published pricing, disclosures and oversight, and the six combine into the 38/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance10/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit20/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs40/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost62/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support48/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness78/100 · Fair

Cancellation is workable but not frictionless.

How we checked this review

Current homepage still advertises semaglutide starting $199 and tirzepatide starting $299. Public page does not establish a complete dose ladder.

Before you sign up

What Spry's public site and signup page show before you hand over any details.

Worth knowing

  • On Spry's website the price is not in the page's own text — it appears only after the page's scripts run
  • Three co-founders are named on-site: Gabriel Mullins, Sara Yoder, and Tyler Bowman
  • No contracts required; a nurse practitioner reviews intake within roughly 24 hours per Spry's own claims
  • Also sells three longevity peptides alongside its GLP-1 program
  • Spry's homepage displays an 'FDA Approved' badge and 'FDA-approved treatments' copy — but compounded semaglutide and tirzepatide are not themselves FDA-approved finished drug products; worth reading that badge skeptically
  • Three named co-founders is more personal accountability than most compounded-GLP-1 storefronts show
  • No state-availability list found, and no pharmacy is named beyond 'FDA-registered compounding facilities' generically
  • Nothing on the site addresses pregnancy, breastfeeding, postpartum timing, or PCOS

Pricing

MedicationPricePlan
Compounded semaglutide$199Starting tier
Compounded tirzepatide$299Starting tierConfirmed the same way. Spry also sells three longevity peptides (BPC-157, NAD+, sermorelin) at $249-$299/mo — not GLP-1s, so left out of these rows rather than mis-tagged.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Spry's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Three named co-founders — more personal accountability than most compounded-GLP-1 storefronts
  • No contracts required, with a stated ~24-hour nurse practitioner review of intake
  • Also offers three longevity peptides if that's of interest beyond weight loss

The caveats

  • Displays an 'FDA Approved' badge over compounded medications that are not themselves FDA-approved finished products
  • No pharmacy named, and no state-availability list found
  • Nothing written specifically for postpartum, breastfeeding, or PCOS

Two starting prices, with a dose question behind them

Spry advertises compounded semaglutide starting at $199 a month and compounded tirzepatide starting at $299. Those figures identify the entry tier for each molecule; they do not establish a complete dose ladder or a ceiling for continued treatment. The difference matters when budgeting beyond the first prescription. Ask what the planned dose costs, whether supplies and shipping are included, and whether a higher prescribed dose changes the payment. A starting price should not become a personal maintenance estimate without those answers.

The company also markets BPC-157, NAD+ and sermorelin. Their prices and proposed purposes belong to separate treatments, rather than alternative GLP-1 rates or necessary parts of a weight-loss package. A broader catalog may be convenient for someone already discussing another therapy with a clinician, but it can also make a simple medication comparison harder. Keep the selected GLP-1 program and any additional purchase itemized, with separate explanations for why each is being offered and what it costs.

The approval badge needs a precise reading

Spry's “FDA Approved” presentation is a material labeling concern because the compounded products it offers are not themselves FDA-approved finished medications. An ingredient's presence in an approved brand does not transfer that approval to a compounded preparation. That distinction affects how to interpret product claims and supporting evidence. It is not an assertion that Spry has received an FDA warning letter. The concern is what a shopper could reasonably understand from the badge above the treatments being sold.

Three co-founders are named: Gabriel Mullins, Sara Yoder and Tyler Bowman. Naming the people behind the service creates a route to accountability, but founder identification is separate from identifying a prescriber or dispensing pharmacy. Spry describes nurse-practitioner review of intake in roughly twenty-four hours and says there are no contracts. Treat the review window as its service claim, not a guaranteed prescription or delivery date. Confirm who takes responsibility when an application needs clarification, a prescription changes, or a shipment cannot be used.

Practical fit depends on answers the storefront leaves open

No specific state list or named compounding pharmacy is published in the available service information. “FDA-registered” facilities, where that wording appears, do not resolve the approval issue or identify the pharmacy that would fill an individual prescription. A prospective patient needs the actual dispensing pharmacy, the formulation and the state-specific availability before evaluating the supply chain. Those details are especially useful when switching providers, because a familiar molecule name can conceal a different concentration or preparation.

Spry also offers little written guidance specific to postpartum recovery, breastfeeding or PCOS. A mother looking for that expertise should ask about the clinician's approach and coordination with her existing care team rather than infer specialization from a general weight-loss service. The no-contract statement is encouraging, but it does not explain cancellation deadlines, refunds after dispensing or what happens to an already processed order. Spry may appeal to someone seeking a comparatively direct online route, provided the dose-dependent bill, pharmacy identity, state eligibility and stopping terms are settled before the first payment. A no-contract offer is most useful when the patient can also find the exact next billing date and a practical method for stopping that charge.

The bottom line for mothers

Best for: A mother who likes seeing named founders behind a brand and will read the 'FDA Approved' badge skeptically rather than at face value.

Alternatives to Spry

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Flat pricing through every dose escalation, named partner pharmacies and a state list it actually publishes — undercut by an open FDA warning letter, an F rating at the BBB, and brand-name pens advertised on its site that you cannot buy.

    Visit Sprout Health
  • Real pre-intake pricing on its GLP-1 pages ($149/mo semaglutide-class B12 combo, $249/mo tirzepatide billed quarterly) inside a much broader TRT-and-men's-health platform — with a strict cancellation policy that refuses cancellations inside 48 hours of a renewal.

    Visit Peter MD

Providers like Spry

Keep comparing Spry

Spry, answered

How much does Spry cost?
At last review, Spry's lowest ongoing compounded rate was about $199/mo — $199/mo for semaglutide, $299/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
Is Spry safe to use while breastfeeding?
No GLP-1 is established as safe in pregnancy. For breastfeeding, the Wegovy injection, Ozempic, Zepbound and Mounjaro labels report little or no data on the drug in breast milk and ask you and your clinician to weigh the benefits of breastfeeding against your need for the medicine. Compounded versions carry no label of their own, which puts more of that judgment on your prescriber. Spry is not an exception to any of that — settle the timing with your own clinician.
Does Spry offer both semaglutide and tirzepatide?
Yes — Spry offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
How does Spry score for mothers?
Spry scores 38/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.

Pricing, states and verification reflect Spry's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers